SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:su-194363"
 

Search: onr:"swepub:oai:DiVA.org:su-194363" > In Silico Mining of...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M-pro) Inhibitors

Ibrahim, Mahmoud A. A. (author)
Abdelrahman, Alaa H. M. (author)
Mohamed, Tarik A. (author)
show more...
Atia, Mohamed A. M. (author)
Al-Hammady, Montaser A. M. (author)
Abdeljawaad, Khlood A. A. (author)
Elkady, Eman M. (author)
Moustafa, Mahmoud F. (author)
Alrumaihi, Faris (author)
Allemailem, Khaled S. (author)
El-Seedi, Hesham R. (author)
Stockholms universitet,Institutionen för molekylär biovetenskap, Wenner-Grens institut,El-Menoufia University, Egypt; Jiangsu University, China
Paré, Paul W. (author)
Efferth, Thomas (author)
Hegazy, Mohamed-Elamir F. (author)
show less...
 (creator_code:org_t)
2021-04-05
2021
English.
In: Molecules. - : MDPI AG. - 1431-5157 .- 1420-3049. ; 26:7
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for the COVID-19 pandemic, which generated more than 1.82 million deaths in 2020 alone, in addition to 83.8 million infections. Currently, there is no antiviral medication to treat COVID-19. In the search for drug leads, marine-derived metabolites are reported here as prospective SARS-CoV-2 inhibitors. Two hundred and twenty-seven terpene natural products isolated from the biodiverse Red-Sea ecosystem were screened for inhibitor activity against the SARS-CoV-2 main protease (M-pro) using molecular docking and molecular dynamics (MD) simulations combined with molecular mechanics/generalized Born surface area binding energy calculations. On the basis of in silico analyses, six terpenes demonstrated high potency as M-pro inhibitors with Delta G(binding) <= -40.0 kcal/mol. The stability and binding affinity of the most potent metabolite, erylosides B, were compared to the human immunodeficiency virus protease inhibitor, lopinavir. Erylosides B showed greater binding affinity towards SARS-CoV-2 M-pro than lopinavir over 100 ns with Delta G(binding) values of -51.9 vs. -33.6 kcal/mol, respectively. Protein-protein interactions indicate that erylosides B biochemical signaling shares gene components that mediate severe acute respiratory syndrome diseases, including the cytokine- and immune-signaling components BCL2L1, IL2, and PRKC. Pathway enrichment analysis and Boolean network modeling were performed towards a deep dissection and mining of the erylosides B target-function interactions. The current study identifies erylosides B as a promising anti-COVID-19 drug lead that warrants further in vitro and in vivo testing.

Subject headings

NATURVETENSKAP  -- Biologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Keyword

drug discovery
marine natural products
molecular docking
molecular dynamics
SARS-CoV-2 main protease
virtual drug screening

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Molecules (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view